134473-73-7

Usage

Uses

Used in Pharmaceutical Industry:
1-Benzyl-3-methoxy-piperidin-4-one is used as a key intermediate in the synthesis of pharmaceutical drugs for its potential biological and pharmacological activities. Its ability to interact with the central nervous system makes it a promising candidate for the development of new therapeutic agents.
Used in Organic Synthesis:
1-Benzyl-3-methoxy-piperidin-4-one is used as a versatile building block in organic synthesis for the creation of new compounds with potential therapeutic properties. Its unique structure allows for the development of innovative molecules with diverse applications in various fields.
Used in Research and Development:
1-Benzyl-3-methoxy-piperidin-4-one is used as a subject of research for its potential use in the treatment of various medical conditions. Scientists and researchers explore its properties and interactions to better understand its potential applications and develop new therapeutic approaches.
Used in Environmental and Health Safety:
1-Benzyl-3-methoxy-piperidin-4-one is used in the development of safety protocols and guidelines for its proper handling and storage. This ensures that the potential risks to human health and the environment are minimized, promoting responsible use of the compound in various applications.

Upstream product

• 127364-15-2 1-phenylmethyl-3-methoxy-4,4-dimethoxypiperidine 

Downstream Products

• 86717-81-9 (cis+trans)-3-methoxy-1-(phenylmethyl)-4-piperidinamine 

Relevant academic research and scientific papers

PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disease, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.

STEREOISOMERIC COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS

The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis,

N-aryl-N-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds

This invention pertains to novel N-aryl-N-[N-substituted 3-alkoxy-4-piperidinyl]amides useful as analgesics, and methods of administering analgesia, which comprises the systemic administration to mammals of such compounds, and pharmaceutical compositions containing such compounds, wherein the novel compounds have the general formula: STR1 including optically active isomeric forms, cis/trans isomeric forms and the pharmaceutically acceptable acid addition salts therof, wherein: R is an aryl group selected from the group consisting of phenyl and substituted phenyl, wherein the substituents on the phenyl group are independently selected from the group consisting of halogen, lower-alkyl, lower-alkoxy, and combinations thereof; R1 is an alkyl group selected from the group consisting of lower-alkyl, lower-alkenyl, and lower-alkoxy lower-alkyl, each alkyl group having from 1 to 6 carbon atoms; R2 is a member selected from the group consisting of phenyl lower-alkyl, thienyl lower-alkyl, pyrazolyl lower-alkyl, tetrazolyl lower-alkyl, 4,5-dihydro-5-oxo-1H-tetrazolyl lower-alkyl, 1,3-dihydro-1,3-dioxo-2H-isoindolyl lower-alkyl, and 2,3-dihydro-2-oxo-1H-benzimidazolyl lower-alkyl; and R3 is a member selected from the group consisting of hydrogen, lower-alkyl and lower-alkyl aryl.

Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives

Novel N-(3-hydroxy-4-piperidinyl)benzamides and derivatives thereof, said compounds being useful as stimulators of the motility of the gastro-intestinal system.